V · Healthcare

Cannara Biotech Inc (LOVE)

Drug Manufacturers - Specialty & Generic

Cannara Biotech Inc (LOVE) is listed on V in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LOVE

P/E ratio

18.00

Cannara Biotech Inc (LOVE) — FAQ

What is LOVE's P/E ratio?

The price-to-earnings (P/E) ratio for Cannara Biotech Inc (LOVE) is 18.00 (data as of 2026-03-22).

Does Cannara Biotech Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cannara Biotech Inc (LOVE). Check the MyAverix Finance app for the latest dividend data.

What sector is Cannara Biotech Inc in?

Cannara Biotech Inc (LOVE) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is LOVE listed on?

LOVE is listed on V.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)